143 related articles for article (PubMed ID: 11981380)
1. Expression of bone morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma fibroblasts.
Schmidt M; Schler G; Gruensfelder P; Hoppe F
Otol Neurotol; 2002 May; 23(3):267-70. PubMed ID: 11981380
[TBL] [Abstract][Full Text] [Related]
2. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
[TBL] [Abstract][Full Text] [Related]
3. Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.
Chung JW; Yoon TH
Acta Otolaryngol; 1998 Jun; 118(3):386-91. PubMed ID: 9655214
[TBL] [Abstract][Full Text] [Related]
4. Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts.
Schmidt M; Grünsfelder P; Hoppe F
Eur Arch Otorhinolaryngol; 2000; 257(8):425-9. PubMed ID: 11073191
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
Koide M; Murase Y; Yamato K; Noguchi T; Okahashi N; Nishihara T
Biochem Biophys Res Commun; 1999 May; 259(1):97-102. PubMed ID: 10334922
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor in middle ear cholesteatoma.
Fujioka O; Huang CC
Eur Arch Otorhinolaryngol; 1994; 251(4):199-204. PubMed ID: 7917251
[TBL] [Abstract][Full Text] [Related]
7. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
[TBL] [Abstract][Full Text] [Related]
8. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
Shinoda H; Huang CC
Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
[TBL] [Abstract][Full Text] [Related]
10. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism.
Schürmann M; Oppel F; Shao S; Volland-Thurn V; Kaltschmidt C; Kaltschmidt B; Scholtz LU; Sudhoff H
Cell Commun Signal; 2021 Feb; 19(1):25. PubMed ID: 33627146
[TBL] [Abstract][Full Text] [Related]
12. Keratinocytes-derived exosomal miRNA regulates osteoclast differentiation in middle ear cholesteatoma.
Gong N; Zhu W; Xu R; Teng Z; Deng C; Zhou H; Xia M; Zhao M
Biochem Biophys Res Commun; 2020 Apr; 525(2):341-347. PubMed ID: 32093888
[TBL] [Abstract][Full Text] [Related]
13. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
Lee RJ; Sidey C; Narula AA; James RF
Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.
Sudhoff H; Dazert S; Gonzales AM; Borkowski G; Park SY; Baird A; Hildmann H; Ryan AF
Am J Otol; 2000 Nov; 21(6):793-8. PubMed ID: 11078065
[TBL] [Abstract][Full Text] [Related]
15. [Hexosoaminidase gene expression in cholesteatoma in adults].
Rutkowska J; Olszewska E; Waniewska E; Czechowska S; Kowalczuk O; Borawska M; Zukowska M; Markiewicz R; Rogowski M
Otolaryngol Pol; 2009; 63(6):490-5. PubMed ID: 20198983
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis.
Lories RJ; Derese I; Ceuppens JL; Luyten FP
Arthritis Rheum; 2003 Oct; 48(10):2807-18. PubMed ID: 14558086
[TBL] [Abstract][Full Text] [Related]
18. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
Liu Y; Cui Y; Yu L; Zhang P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
[TBL] [Abstract][Full Text] [Related]
20. [Role of perimatrix fibroblasts in development of acquired middle ear cholesteatoma. A hypothesis].
Milewski C
HNO; 1998 May; 46(5):494-501. PubMed ID: 9647920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
